je.st
news
Tag: medicine
Cow Fixer Vs. Herd Health Veterinarian? BEEF Vet Examines Production Medicine
2013-05-25 13:32:00| Beef
Effective production medicine is a mind-set as much as the multiple disciplines that comprise it. Beef industry vets explain why fellow DVMs must become herd health veterinarians, rather than "cow fixers." read more
Tags: health
production
medicine
vet
Merck Provides Update on Phase III Clinical Program for Preladenant, the Companys Investigational Parkinsons Disease Medicine
2013-05-23 23:00:00| Merck.com - Research & Development News
Dateline City: WHITEHOUSE STATION, N.J. WHITEHOUSE STATION, N.J.--(BUSINESS WIRE)--Merck (NYSE: MRK), known as MSD outside the United States and Canada, today provided an update on the clinical program for preladenant, Mercks investigational adenosine A2A receptor antagonist for the treatment of Parkinsons disease (PD). An initial review of data from three separate Phase III trials did not provide evidence of efficacy for preladenant compared with placebo. Language: English Contact HTML: MerckMedia Contacts:Pam Eisele, 908-423-5042orClaire Mulhearn, 908-423-7425orInvestor Contacts:Carol Ferguson, 908-423-4465orJustin Holko, 908-423-5088 Ticker Slug: Ticker: MRK Exchange: NYSE read more
Tags: program
iii
update
medicine
Merck & Co., Inc. and Pfizer Enter Worldwide Collaboration Agreement to Develop and Commercialize Ertugliflozin, an Investigational Medicine for Type 2 Diabetes
2013-04-29 13:30:00| Merck.com - Research & Development News
Dateline City: WHITEHOUSE STATION, N.J. & NEW YORK WHITEHOUSE STATION, N.J. & NEW YORK--(BUSINESS WIRE)--Merck & Co., Inc. (NYSE: MRK), known as MSD outside the United States and Canada (Merck), and Pfizer Inc. (NYSE:PFE) today announced that they have entered into a worldwide (except Japan) collaboration agreement for the development and commercialization of Pfizers ertugliflozin (PF-04971729), an investigational oral sodium glucose cotransporter (SGLT2) inhibitor being evaluated for the treatment of type 2 diabetes. Language: English Contact HTML: Merck Media Relations:Steven Cragle: (908) 423-3461Kim Hamilton: (908) 423-6831orPfizer Media Relations:Joan Campion: (212) 733-2798orMerck Investor Relations:Carol Ferguson: (908) 423-4465Justin Holko: (908) 423-5088orPfizer Investor Relations:Chuck Triano: (212) 733-3901 Ticker Slug: Ticker: MRK Exchange: NYSE Ticker: PFE Exchange: NYSE read more
Tags: for
type
enter
agreement
Things Go Better as Coke Supply Chain Delivers Medicine to Remote African Villages
2013-04-27 12:56:39| Beverages - Topix.net
Women in rural areas of the developing world often have to walk all day to get to a health clinic to retrieve the oral rehydration packets needed to treat their children's diarrhea, a leading killer for those under the age of five.
Tags: things
supply
medicine
chain
Life Technologies' Ion Proton(TM) to Power Stratified Medicine Scotland Innovation Centre
2013-04-23 06:00:00| Industrial Newsroom - All News for Today
Innovation Centre's ambitious approach to treatment of disease to dramatically improve patient outcomes whilst reducing overall healthcare costs.<br /> <br /> GLASGOW, Scotland - Life Technologies Corporation (NASDAQ: LIFE) today announces that it is a lead commercial partner along with Aridhia, a bio-medical informatics company, in the Stratified Medicine Scotland Innovation Centre (SMS-IC). The Ion Proton™ sequencing platform will be the primary tool to drive discovery and genetic ...This story is related to the following:DNA Sequencers
Tags: life
power
centre
medicine
Sites : [23] [24] [25] [26] [27] [28] [29] [30] [31] [32] [33] [34] [35] [36] next »